Alvotech
ALVOW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVO
Q4 2025 vs. Q3 2025
How the institutions holding Alvotech changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 10 | 8 | −2 |
| Shares | 5.10M | 5.05M | −50.1K (−1.0%) |
| Value | $7.74M | $3.30M | −$4.44M (−57.4%) |
New holders (1)
Institutions that held Alvotech at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wolverine Asset Management LLC | 18,716 | $12.2K | 0.00% |
Sold out (3)
Institutions that held Alvotech at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Arena Capital Advisors, LLC- CA | 60,714 | $92.2K |
| Highbridge Capital Management LLC | – | $8.88K |
| Clear Street Group Inc. | 5,828 | $8.85K |